60 DEGREES PHARMACEUTICALS, INC. — Investor Relations & Filings
Filings indexed
192
across all filing types
Latest filing
2026-05-18
Regulatory Filings
Country
US
United States of America
Listing
US
SXTP
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of medicines for infectious diseases. The company's primary efforts are directed towards tropical diseases with significant unmet medical needs. Its portfolio includes a commercially available product for malaria prevention and a development program for a dengue fever treatment. The company's clinical pipeline also extends to other infectious diseases, such as babesiosis. Through collaborations with research organizations, 60 Degrees Pharmaceuticals aims to discover, develop, and distribute innovative therapies for patients worldwide.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| CURRENT REPORT | 2026-05-18 | English | |
| 10-Q | 2026-05-15 | English | |
| 8-K - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Filer) | 2026-03-20 | English | |
| 8-K Filing | 2026-02-12 | English | |
| CURRENT REPORT | 2026-01-23 | English | |
| CURRENT REPORT | 2026-01-21 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 46460988 | CURRENT REPORT | 2026-05-18 | English | ||
| 46353984 | 10-Q | 2026-05-15 | English | ||
| 33002179 | 8-K - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Filer) | 2026-03-20 | English | ||
| 32241028 | 8-K Filing | 2026-02-12 | English | ||
| 13618397 | CURRENT REPORT | 2026-01-23 | English | ||
| 13618398 | CURRENT REPORT | 2026-01-21 | English | ||
| 13618399 | CURRENT REPORT | 2026-01-08 | English | ||
|
2025
8 filings
| |||||
| 13618401 | Director's Dealing 2025 | 2025-12-16 | English | ||
| 13618400 | OWNERSHIP DOCUMENT | 2025-12-12 | English | ||
| 13618402 | Major Shareholding Notification 2025 | 2025-11-13 | English | ||
| 13618404 | 10-Q | 2025-11-13 | English | ||
| 13618403 | Major Shareholding Notification 2025 | 2025-11-07 | English | ||
| 13618405 | Major Shareholding Notification 2025 | 2025-11-07 | English | ||
| 13618406 | CURRENT REPORT | 2025-10-10 | English | ||
| 13618407 | Director's Dealing 2025 | 2025-09-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
60 DEGREES PHARMACEUTICALS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35377/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35377 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35377 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35377 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35377}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for 60 DEGREES PHARMACEUTICALS, INC. (id: 35377)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.